Southlake, TX — HeartSciences Inc. (Nasdaq: HSCS / HSCSW) announced the commercial launch of MyoVista Insights Version 1.1, a major usability upgrade designed around feedback from cardiology and primary-care early adopters.
Version 1.1 introduces a redesigned worklist with critical-finding prioritization, longitudinal ECG comparison overlays, and a streamlined caliper / waveform measurement experience. Together, these changes shorten the time clinicians spend per ECG and surface AI and device algorithm findings in a single unified view.
"Version 1.1 is designed to provide the best usability of any ECG system," said Andrew Simpson, CEO of HeartSciences. "Our early adopters have been generous with their feedback, and we have shipped what they asked for — without disrupting their existing workflows."
Investor contact
Mark Komonoski, Integrous Communications · 877-255-8483 · [email protected]